These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18665584)

  • 41. Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.
    Pham KN; Lewis-Ballester A; Yeh SR
    J Am Chem Soc; 2019 Nov; 141(47):18771-18779. PubMed ID: 31682426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical properties of indoleamine 2,3-dioxygenase: from structure to optimized design of inhibitors.
    Lancellotti S; Novarese L; De Cristofaro R
    Curr Med Chem; 2011; 18(15):2205-14. PubMed ID: 21517759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indoleamine 2,3-dioxygenase inhibitors: a patent review (2008 - 2012).
    Dolušić E; Frédérick R
    Expert Opin Ther Pat; 2013 Oct; 23(10):1367-81. PubMed ID: 23992582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors.
    Delfourne E
    Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2).
    Röhrig UF; Majjigapu SR; Caldelari D; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Zoete V; Michielin O
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4330-3. PubMed ID: 27469130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of potent indoleamine 2,3-dioxygenase (IDO) inhibitor from alkaloids in Picrasma quassioides by virtual screening and in vitro evaluation.
    Wang N; Zhang J; Li Q; Xu H; Chen G; Li Z; Liu D; Yang X
    Fitoterapia; 2019 Mar; 133():137-145. PubMed ID: 30654128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Dolušić E; Larrieu P; Blanc S; Sapunaric F; Norberg B; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
    Bioorg Med Chem; 2011 Feb; 19(4):1550-61. PubMed ID: 21269836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies.
    Selvan SR; Dowling JP; Kelly WK; Lin J
    Curr Cancer Drug Targets; 2016; 16(9):755-764. PubMed ID: 26517538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
    ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of Clinical Candidate (1
    Kumar S; Waldo JP; Jaipuri FA; Marcinowicz A; Van Allen C; Adams J; Kesharwani T; Zhang X; Metz R; Oh AJ; Harris SF; Mautino MR
    J Med Chem; 2019 Jul; 62(14):6705-6733. PubMed ID: 31264862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Michielin O; Zoete V
    J Med Chem; 2021 Feb; 64(4):2205-2227. PubMed ID: 33557523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of exiguamine A analogues as IDO1 inhibitors.
    Dong J; Pan X; Yang Y; Zhang G; Xiao Z; Liu Z
    Eur J Med Chem; 2021 Nov; 223():113631. PubMed ID: 34147748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
    Weng T; Qiu X; Wang J; Li Z; Bian J
    Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of indoleamine 2,3-dioxygenase activity by fatty acids and prostaglandins: A structure function analysis.
    Costabile M; Bassal NK; Gerber JP; Hughes BP
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jul; 122():7-15. PubMed ID: 28735627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
    Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
    J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.